Cardiac monitoring

Study Published in JAMA Cardiology Finds Zio by iRhythm Proactively Identifies Atrial Fibrillation, Increases Detection Tenfold

Wednesday, February 24, 2021 - 4:00pm

The transatlantic clinical trial found that Zio by iRhythm , an ambulatory cardiac monitoring solution, led to a tenfold increase in the detection of atrial fibrillation (AF) versus patients receiving standard clinical care.

Key Points: 
  • The transatlantic clinical trial found that Zio by iRhythm , an ambulatory cardiac monitoring solution, led to a tenfold increase in the detection of atrial fibrillation (AF) versus patients receiving standard clinical care.
  • The study results lend support for Zio as a screening tool for early detection of AF.
  • iRhythm is a leading digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed.
  • The company believes improvements in arrhythmia detection and characterization have the potential to change the clinical management of patients.

CB Scientific, Inc. Discusses the Potential of Their Proprietary Cardiac Event Monitor, my-Cam, with The Stock Day Podcast

Tuesday, February 23, 2021 - 2:00pm

asked Jolly, after commenting on the Company's proprietary my-Cam cardiac event monitor.

Key Points: 
  • asked Jolly, after commenting on the Company's proprietary my-Cam cardiac event monitor.
  • "Today, with ambulatory remote cardiac event monitoring, there are actually four modalities that are offered," explained Martin, before elaborating on these technologies.
  • "Our device is cardiac event monitoring, which is a device that can be worn for up to 30 days," said Martin.
  • "That particular application has evolved into what's called cardiac event monitoring, which is on the marketplace today, primarily in the US."

RhythMedix Launches Next-Generation RhythmStar® Device, the First and Only Wearable Cardiac Monitor with Built-In Cellular Connectivity

Thursday, February 18, 2021 - 1:01pm

MOUNT LAUREL, N.J., Feb. 18, 2021 /PRNewswire/ -- RhythMedix , a leader in remote cardiac monitoring, today announced the release of its next-generation RhythmStar wearable device with built-in 4G cellular connectivity.

Key Points: 
  • MOUNT LAUREL, N.J., Feb. 18, 2021 /PRNewswire/ -- RhythMedix , a leader in remote cardiac monitoring, today announced the release of its next-generation RhythmStar wearable device with built-in 4G cellular connectivity.
  • The novel cardiac telemetry monitor is discreetly worn for extended remote monitoring without the need for an additional phone or communication device.
  • The sleek, one-piece device, with built-in 4G cellular technology, is the first wearable multi-modality cardiac monitor (Holter, Event and MCT) that connects patients and clinicians for improved patient care.
  • RhythMedix, a privately owned medical device manufacturer, provides innovative technology to transform the medical monitoring industry and improve patient outcomes.

VivaLNK Offers Untethered Wearable ECG Monitor Solution for Six-Minute Walk Test

Tuesday, February 16, 2021 - 2:00pm

CAMPBELL, Calif., Feb. 16, 2021 /PRNewswire/ -- VivaLNK , a leading provider of connected healthcare solutions, announces availability of a wearable ECG monitoring solution designed to wirelessly capture ECG and heart rate during a six-minute walk test (6MWT).

Key Points: 
  • CAMPBELL, Calif., Feb. 16, 2021 /PRNewswire/ -- VivaLNK , a leading provider of connected healthcare solutions, announces availability of a wearable ECG monitoring solution designed to wirelessly capture ECG and heart rate during a six-minute walk test (6MWT).
  • It involves monitoring a patient while they walk as far as they can in a six-minute period and assessing cardiopulmonary function.
  • In these studies, patients wear the wireless ECG patch while a clinician is able to monitor and control the test using a mobile app.
  • At only 7.5 grams, VivaLNK's unique wearable ECG monitor is barely noticeable when worn.

Global Patient Monitoring Devices Market Report 2020-2027: Availability of Services Such as Home Healthcare and Nursing Care Increasing the Demand for the Use of Patient Monitoring Devices

Friday, February 12, 2021 - 1:00pm

However, the high cost of patient monitoring devices, stringent regulatory approvals for products, Patient safety and inaccuracy concerns associated with patient monitoring devices, increased product recalls are restraining the market growth.

Key Points: 
  • However, the high cost of patient monitoring devices, stringent regulatory approvals for products, Patient safety and inaccuracy concerns associated with patient monitoring devices, increased product recalls are restraining the market growth.
  • The patient monitoring devices global market is segmented based on device, portability, end-users and geography.
  • The devices market is segmented into neuromonitoring, hemodynamic monitoring, blood glucose monitoring, cardiac monitoring, fetal & neonatal care monitoring, respiratory care monitoring, multi-parameter monitoring, temperature monitoring and remote patient monitoring.
  • The remote patient monitoring (RPM) devices are classified into hemodynamic monitoring devices, neuromonitoring devices, cardiac monitoring devices and multi-parameter monitoring devices and others.

New Study Published in JACC Clinical EP Validates that Cardiologs' AI Eliminates Nearly Two-Thirds of False Positives in Remote Monitoring for Atrial Fibrillation

Wednesday, February 10, 2021 - 8:18pm

The findings show that Cardiologs' AI-based ECG analysis solution significantly reduces the rate of false positive atrial fibrillation (AFib) detection in remote cardiac monitoring of patients with implantable loop recorders (ILRs).

Key Points: 
  • The findings show that Cardiologs' AI-based ECG analysis solution significantly reduces the rate of false positive atrial fibrillation (AFib) detection in remote cardiac monitoring of patients with implantable loop recorders (ILRs).
  • Cardiologs and Valley Health tracked a cohort of 425 patients who received an ILR for known AFib or cryptogenic stroke.
  • Since ILRs transmit data daily, these false positives are one of the Achilles heels of remote cardiac monitoring.
  • Publication of our successful trial results in JACC EP further validates the considerable promise of our solution for the clinical community.

Worldwide Cardiac Monitoring & Cardiac Rhythm Management Industry to 2027 - by End-user, Product and Geography

Thursday, February 4, 2021 - 3:45pm

DUBLIN, Feb. 4, 2021 /PRNewswire/ -- The "Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 4, 2021 /PRNewswire/ -- The "Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Cardiac Monitoring & Cardiac Rhythm Management market accounted for $25,152.56 million in 2019 and is expected to reach $48,665.45 million by 2027 growing at a CAGR of 8.6% during the forecast period.
  • Cardiac rhythm management maintains a normal cardiac rhythm in patients suffering from irregular heart rate and rhythm disorder.
  • The cardiac monitoring & cardiac rhythm management include devices that help the patients to manage and treat arrhythmia-related diseases.

Pylo Launches 4G Blood Pressure Monitor for Remote Patient Monitoring

Wednesday, February 3, 2021 - 1:32pm

LOS ANGELES, Feb. 3, 2021 /PRNewswire/ --Pylo Health proudly announced today the release of the Pylo 802-LTE, a cellular blood pressure monitor designed for patients undergoing remote physiological monitoring (RPM).

Key Points: 
  • LOS ANGELES, Feb. 3, 2021 /PRNewswire/ --Pylo Health proudly announced today the release of the Pylo 802-LTE, a cellular blood pressure monitor designed for patients undergoing remote physiological monitoring (RPM).
  • While operating like a traditional blood pressure monitor to patients, the 802-LTE quickly captures and transmits accurate blood pressure and heart rate measurements via encrypted 4G wireless sync to the intuitive Pylo application programming interface (API).
  • "Many patients who need to monitor their blood pressure are not tech savvy," says Daniel Tashnek, founder of Pylo and Prevounce Health.
  • "Research has shown that remote cardiac monitoring can greatly reduce patient blood pressure compared to typical care and self-monitoring alone," Tashnek says.

Global Cardiac Monitoring & Cardiac Rhythm Management Market Outlook to 2027 - Players Include Stryker, St. Jude Medical and Siemens Among Others - ResearchAndMarkets.com

Wednesday, February 3, 2021 - 12:48pm

The "Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Cardiac Monitoring & Cardiac Rhythm Management market accounted for $25,152.56 million in 2019 and is expected to reach $48,665.45 million by 2027 growing at a CAGR of 8.6% during the forecast period.
  • Cardiac rhythm management maintains a normal cardiac rhythm in patients suffering from irregular heart rate and rhythm disorder.
  • The cardiac monitoring & cardiac rhythm management include devices that help the patients to manage and treat arrhythmia-related diseases.

IRHYTHM ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against iRhythm Technologies, Inc. and Encourages Investors to Contact the Firm

Tuesday, February 2, 2021 - 2:30am

Investors have until April 2, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until April 2, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • iRhythm offers a portfolio of ambulatory cardiac monitoring services on its platform, called the Zio service.
  • On January 29, 2021, Medicare Administrative Contractor Novitas Solutions published actual reimbursement rates under the CMS 2021 Medicare Physician Fee Schedule.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.